Clinical Trial Update: A Pharmacokinetic Study to Evaluate the Effect of Antacids on Raltegravir (MK-0518) in HIV-Infected Participants (MK-0518-247) [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating the effect of antacids on raltegravir exposure in HIV-infected participants, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2013-09-17